Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

ClinicalTrials.gov ID: NCT07172516

Public ClinicalTrials.gov record NCT07172516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with bipolar I or II disorder who are currently in a depressive episode (bipolar depression).

Study identification

NCT ID
NCT07172516
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xenon Pharmaceuticals Inc.
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 8, 2025 (Actual)
Primary completion
Jun 2028 (Estimated)
Completion
Aug 2028 (Estimated)
Last update posted
Oct 13, 2026

2025 – 2028

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Noble Clinical Research Tucson Arizona 85704 —
Woodland International Research Group Little Rock Arkansas 72211 —
Woodland Research Northwest Rogers Arkansas 72758 —
Clinical Innovations Inc Bellflower California 90706 —
ProScience Research Group Culver City California 90230 —
ATP Clinical Research Orange California 92866 —
NRC Research Institute Orange California 92868 —
Clinical Innovations Inc Riverside California 92506 —
Sunwise Clinical Research Walnut Creek California 94596 —
PharmaSouth Research, LLC Coral Gables Florida 33146 —
Sarkis Clinical Research Gainesville Florida 32607 —
Clinical Neuroscience Solutions, LLC Jacksonville Florida 32256 —
Central Miami Medical Institute Miami Florida 33125 —
Clinical Neuroscience Solutions, LLC Orlando Florida 32801 —
Synexus Clinical Research, Inc. Atlanta Georgia 30328 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
CenExel iResearch Decatur Georgia 30030 —
Denali Health Atlanta, LLC Stone Mountain Georgia 30083 —
Revival Research Institute Elgin Illinois 60123 —
Advanced Quality Medical Research Orland Park Illinois 60462 —
Psychiatric Care and Research Center O'Fallon Missouri 63368 —
Redbird Clinical Research, LLC Las Vegas Nevada 89119 —
Lumina Clinical Research Center Cherry Hill New Jersey 08002 —
Bio Behavioral Health Toms River New Jersey 08755 —
Integrative Clinical Trials LLC Brooklyn New York 11229 —
Neurobehavioral Research Inc Cedarhurst New York 11516 —
Richmond Behavioral Associates Staten Island New York 10314 —
DelRicht Research Charlotte North Carolina 28210 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18103 —
Clinical Neuroscience Solutions, LLC Memphis Tennessee 38119 —
Elevate Synapsis, LLC Atascocita Texas 77346 —
Memorial Hermann Village Houston Texas 77043 —
Grayline Research Center Wichita Falls Texas 76309 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07172516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07172516 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →